Published November, 2021
By Peter Beresford and Jasna Russo
Publisher: Taylor & Francis (Routledge)
Rating:
Availability: Available

By drawing broadly on international thinking and experience, this book offers a critical exploration of mad studies and advances its theory and practice.

---

Published November, 2021
By Marc Galanter, Nady el-Guebaly, Giuseppe Carra and Alexander M. Baldacchino
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available

---

Published November, 2021
By Ed Day
Publisher: Cambridge University Press (RCPsych/Cambridge University Press)
Rating: 1.00
Availability: Available

---

Published November, 2021
By Samuel O. Okpaku
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

Over the course of the last decade, political and mental entities at large have embraced global mental health: the idea that psychiatric health is vital to improved quality of life.

---

Published October, 2021
By Nancy A. Dodson
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

It describes the epidemiology of teen gun violence in the U.S. by focusing on the parallel epidemics that claim the most lives: gun suicide among rural white males, and gun homicide among urban Black males.

---

Published October, 2021
By Kylie O'Brien and Philip Blair
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available

It conveys the scientific evidence of efficacy of CBD as well as THC and addresses the social stigma attached to its medical use.The book describes the endocannabinoid system, how stress and the endocannabinoid system interact and key constituents, pharmacokinetics and safety aspects of medicinal cannabis, focusing on CBD and THC.

---

Published October, 2021
By Giovanni A. Fava and Giovanni Fava
Publisher: Oxford University Press
Rating:
Availability: Available

The handbook guides clinicians through the challenge of discontinuing antidepressants in their patients, by providing updated information that may help to determine if discontinuation of antidepressant drugs is feasible for a patient; what the counter-indications would be for stopping or continuing; and how discontinuation can be achieved.

---

Published October, 2021
By Fred R. Volkmar, Denis G. Sukhodolsky and Eli R. Lebowitz
Publisher: Lippincott Williams & Wilkins (Wolters Kluwer Health)
Rating: 1.00
Availability: Available

---

Published October, 2021
By Anne M. Doherty, Aoife M. Egan and Sean Dinneen
Publisher: Cambridge University Press (RCPsych/Cambridge University Press)
Rating: 1.00
Availability: Available

---

Published October, 2021
By Stephen P. Hinshaw, Benjamin B. Lahey and Benjamin Lahey
Publisher: Oxford University Press (Oxford University Press Inc)
Rating: 1.00
Availability: Available

---